The SARS-CoV-2 virus has been identified as the cause of COVID-19. COVID-19 is now a global pandemic that has infected over 80.68 million people and caused over 1.76 million deaths as of 7:35 p.m. on December 26, 2020. You can click on the link to see how many have been infected and how many have died at the time you are reading this article.
This article will discuss the types of vaccines under development, access the risk of getting COVID-19 versus the risk of side-effects from a vaccine, and recommend actions based upon the data. Vaccines do not kill the viruses that they are intended to prevent.
This article will briefly discuss the importance of increasing the body’s immune function to lessen the risk of infection. The mortality of COVID-19 infections has been tied to compromised immune functions, with age, diabetes, heart, and lung disorders among the top causes of death due to COVID-19.
The article will then discuss standard approaches for treating COVID-19 patients, and discuss an alternative approach that is becoming widely used in the ICU’s of the US and in foreign countries to prevent and treat COVID-19 with an approach that does not involve a vaccine.
The benefits of currently released vaccines from Pfizer and Moderna for the prevention of COVID-19 infections far outweigh the risk of life-threatening side-effects of these two COVID-19 vaccines. Life-threatening allergic reactions or viral diseases resulting from the testing of various COVID-19 vaccines are extremely rare. The risks of death from COVID-19 and the long-term effects of having been treated in an ICU for COVID-19 are significant in frequency and effect.
The risk of becoming infected by COVID-19 at this moment in time in the US is estimated at about 15% of those tested. There is no federal reporting standard. John Hopkins University’s Coronavirus Research Center provides infection and death values by states in the US and by country around the world.
The reaction to the global pandemic caused by the SARS-CoV-2 virus has been to develop vaccines to prevent infections. The CDC has provided a detailed list of the approaches used in creating COVID-19 vaccines. These vaccines should be able to prevent mutations of the SARS-CoV-2, but that has not been proven. The length of immunity that is related to the COVID-19 vaccines have not been established.
Increased Immune Function:
The immune system provides the mechanism to protect the body from attacks by viral and bacterial infections. Vaccines trigger the immune system to produce various specialized cells to attack invading viruses. Substances that increase immune function reduce the probability of viral infections, and improve the efficacy of vaccines. There has been significant scientific research done on what can be done to increase immune function. There are also scientific studies done in the US and India that show simple ways to decrease the SARS-CoV-2 viral load in the nasal cavities and salivary glands.
Treatment of COVID-19:
There is a widely held myth that there are no available drugs that can kill viruses in our bodies. There are four FDA approved antiviral drugs for the flu. There is now an FDA drug approved for the treatment of HIV. The FDA has approved remdesivir as a treatment for SARS-CoV-2. This is a new drug that was used to treat President Trump. It is not widely available, and it is expensive. The estimated cost of using remdesivir is $4,000 for severe cases and $700 for moderate cases. The World Health Organization has concluded that remdesivir has no effect on reducing mortality from COVID-19. The FDA has approved remdesivir for treatment of COVID-19 infections, with substantial pressure from one notable recipient.
There is an alternate solution being utilized by ICU doctors in the US that is implemented with a combination of FDA approved drugs and supplements that have been approved for applications other than COVID-19. The drug is ivermectin. The original developers of this drug received the Nobel Prize in Medicine in 2015. Ivermectin has been used to treat hundreds of millions of people around the globe for a wide variety of conditions.
The Covid-19 Treatment Panel has specifically declared that ivermectin is not approved for use in treating COVID-19 patients except for studies. This is despite an analysis published by the NIH regarding ivermectin’s wide use on hundreds of millions of people around the world.
“Ivermectin is already labelled a ‘wonder drug’, essential for campaigns to eliminate two disfiguring and devastating tropical diseases. New uses for it are identified regularly, including possible antibacterial, antiviral, and anticancer potential. Hundreds of millions of people are taking ivermectin to combat various diseases and afflictions, and mass administration of ivermectin in polyparasitised poor communities around the world is increasingly recognized as a mechanism to easily and cost-effectively improve overall health and quality of life for everyone.”
Those physicians engaged in treating COVID-19 ICU patients have formed a group called Front-Line COVID Critical Care, flccc.net. Ivermectin is being extensively tested around the world. Studies were done in Brazil and Peru by comparing actual infection rates and deaths from COVID-19 infection in municipal areas that did and did not use ivermectin in treating COVID-19 patients. The results were statistically significant.
There is an extensive analysis of the results of using ivermectin to treat COVID-19 ICU patients, and also using ivermectin as a prophylactic regimen to prevent COVID-19 infection. There is a one-page summary of the current status of establishing the efficacy of ivermectin in treating COVID-19 patients. Ivermectin has been provided to hundreds of millions of patients for treatment of tropical parasites that cause blindness and death. Ivermectin has a record of safe use in the general population of these countries.
Given the dire situations across the US with regard to inadequate ICU treatment facilities after the Thanksgiving surge in new COVID-19 cases, it is very important to have rapid and thorough testing of ivermectin for prevention of COVID-19 infections, and treatments using COVID-19 with other appropriate drugs to reduce mortality and length-of-stay in hospitals. If this article is considered to be useful, you might forward it to your state Health Department, your Congressional senators, and representatives. (The Health Department link is for Ohio. The links to senators and representatives will help you wherever you are located if you enter your Zip code where instructed.)
Relevant videos and articles: